会員登録
ログイン
【4587】ペプチドリーム
ペプチド医薬品。
類似企業：
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.12 | 2024/11/13 | Q3予 | 45,000 | → | 0.0% | +28.6% | 20,100 | → | 0.0% | +91.4% | 19,900 | → | 0.0% | +95.1% | 14,000 | → | 0.0% | +91.8% |
| 2024.12 | 2024/08/08 | Q2予 | 45,000 | → | 0.0% | +28.6% | 20,100 | → | 0.0% | +91.4% | 19,900 | → | 0.0% | +95.1% | 14,000 | → | 0.0% | +91.8% |
| 2024.12 | 2024/05/14 | Q1予 | 45,000 | ↑ | +28.6% | +28.6% | 20,100 | ↑ | +91.4% | +91.4% | 19,900 | ↑ | +95.1% | +95.1% | 14,000 | ↑ | +91.8% | +91.8% |
| 2024.12 | 2024/02/14 | 当初予 | 35,000 | - | - | - | 10,500 | - | - | - | 10,200 | - | - | - | 7,300 | - | - | - |
| 2023.12 | 2024/02/14 | 実 | 28,712 | ↓ | -4.3% | -4.3% | 6,773 | ↑ | +7.5% | +7.5% | 4,353 | ↑ | +17.6% | +17.6% | 3,035 | ↑ | +12.4% | +12.4% |
| 2023.12 | 2023/11/09 | Q3予 | 30,000 | → | 0.0% | 0.0% | 6,300 | → | 0.0% | 0.0% | 3,700 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% |
| 2023.12 | 2023/08/09 | Q2予 | 30,000 | → | 0.0% | 0.0% | 6,300 | → | 0.0% | 0.0% | 3,700 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% |
| 2023.12 | 2023/05/11 | Q1予 | 30,000 | → | 0.0% | 0.0% | 6,300 | → | 0.0% | 0.0% | 3,700 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% |
| 2023.12 | 2023/02/14 | 当初予 | 30,000 | - | - | - | 6,300 | - | - | - | 3,700 | - | - | - | 2,700 | - | - | - |
| 2022.12 | 2023/02/14 | 実 | 26,852 | ↑ | +9.6% | +9.6% | 8,980 | ↑ | +47.2% | +47.2% | 6,653 | ↑ | +10.9% | +10.9% | 7,554 | ↑ | +79.9% | +79.9% |
| 2022.12 | 2022/11/10 | 当初予 | 24,500 | - | - | - | 6,100 | - | - | - | 6,000 | - | - | - | 4,200 | - | - | - |
| 2021.12 | 2022/02/09 | 実 | 9,365 | - | - | - | 4,418 | - | - | - | 4,774 | - | - | - | 3,606 | - | - | - |
| 2020.12 | 2021/02/10 | 実 | 11,677 | - | - | - | 6,991 | - | - | - | 6,976 | - | - | - | 4,448 | - | - | - |
| 2019.12 | 2020/02/13 | 実 | 1,037 | - | - | - | -887 | - | - | - | -706 | - | - | - | -488 | - | - | - |
| 2019.06 | 2019/08/08 | 実 | 7,216 | - | - | - | 3,579 | - | - | - | 3,806 | - | - | - | 2,770 | - | - | - |
| 2018.06 | 2018/08/09 | 実 | 6,426 | - | - | - | 2,910 | - | - | - | 3,154 | - | - | - | 2,335 | - | - | - |
| 2017.06 | 2017/08/09 | 実 | 4,895 | - | - | - | 2,490 | - | - | - | 2,624 | - | - | - | 1,890 | - | - | - |
| 2016.06 | 2016/08/09 | 実 | 4,327 | ↑ | +39.7% | +39.7% | 2,548 | ↑ | +94.8% | +94.8% | 2,372 | ↑ | +87.2% | +87.2% | 1,581 | ↑ | +89.3% | +89.3% |
| 2016.06 | 2016/05/10 | Q3予 | 3,097 | → | 0.0% | 0.0% | 1,308 | → | 0.0% | 0.0% | 1,267 | → | 0.0% | 0.0% | 835 | → | 0.0% | 0.0% |
| 2016.06 | 2016/02/05 | Q2予 | 3,097 | → | 0.0% | 0.0% | 1,308 | → | 0.0% | 0.0% | 1,267 | → | 0.0% | 0.0% | 835 | → | 0.0% | 0.0% |
| 2016.06 | 2015/11/10 | Q1予 | 3,097 | → | 0.0% | 0.0% | 1,308 | → | 0.0% | 0.0% | 1,267 | → | 0.0% | 0.0% | 835 | → | 0.0% | 0.0% |
| 2016.06 | 2015/08/11 | 当初予 | 3,097 | - | - | - | 1,308 | - | - | - | 1,267 | - | - | - | 835 | - | - | - |
| 2015.06 | 2015/08/11 | 実 | 2,474 | ↑ | +11.3% | +43.5% | 1,391 | ↑ | +46.0% | +120.4% | 1,496 | ↑ | +44.8% | +162.5% | 1,004 | ↑ | +54.0% | +173.6% |
| 2015.06 | 2015/05/12 | Q3予 | 2,222 | ↑ | +28.9% | +28.9% | 953 | ↑ | +51.0% | +51.0% | 1,033 | ↑ | +81.2% | +81.2% | 652 | ↑ | +77.7% | +77.7% |
| 2015.06 | 2015/02/10 | Q2予 | 1,724 | → | 0.0% | 0.0% | 631 | → | 0.0% | 0.0% | 570 | → | 0.0% | 0.0% | 367 | → | 0.0% | 0.0% |
| 2015.06 | 2014/11/11 | Q1予 | 1,724 | → | 0.0% | 0.0% | 631 | → | 0.0% | 0.0% | 570 | → | 0.0% | 0.0% | 367 | → | 0.0% | 0.0% |
| 2015.06 | 2014/08/12 | 当初予 | 1,724 | - | - | - | 631 | - | - | - | 570 | - | - | - | 367 | - | - | - |
| 2014.06 | 2014/08/12 | 実 | 818 | - | - | - | 201 | - | - | - | 221 | - | - | - | 148 | - | - | - |
